#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11536	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2077	546.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1682	1682	T	674	T,C	652,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11536	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2077	546.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	610	C,A	586,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3587	595.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1681	1681	A	742	A,G	714,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3587	595.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	705	C	673	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3587	595.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	672	A	653	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21592	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3587	595.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	664	C,T,G	634,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1496	folP	855	855	100.0	folP.l6.c4.ctg.1	1463	100.9	1	SNP	p	R229S	1	.	.	685	687	AGC	970	972	AGC	165;164;166	A;G;C	158;157;153	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4328	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3345	127.5	1	SNP	p	S91F	1	.	.	271	273	TTC	533	535	TTC	123;121;124	T;T;C	117;116;120	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4328	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3345	127.5	1	SNP	p	G95N	0	.	.	283	285	GGC	545	547	GGC	121;119;119	G;G;C	119;115;115	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4328	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3345	127.5	1	SNP	p	D95G	1	.	.	283	285	GGC	545	547	GGC	121;119;119	G;G;C	119;115;115	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1414	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1300	106.8	1	SNP	p	G45D	0	.	.	133	135	GGC	507	509	GGC	182;177;178	G,C;G,C;C	170,1;170,1;171	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	692	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	817	82.2	0	.	n	.	0	A197.	DEL	197	197	A	457	457	A	153	A	149	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1434	1436	GTC	141;140;136	G;T;C	133;131;128	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	1	SNP	p	D86N	0	.	.	256	258	GAC	540	542	GAC	142;143;144	G;A;C	137;132;140	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	1	SNP	p	R87W	0	.	.	259	261	CGT	543	545	CGT	145;146;147	C;G,A;T	140;141,1;142	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	1	SNP	p	R87I	0	.	.	259	261	CGT	543	545	CGT	145;146;147	C;G,A;T	140;141,1;142	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	1	SNP	p	S87R	1	.	.	259	261	CGT	543	545	CGT	145;146;147	C;G,A;T	140;141,1;142	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3908	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2948	131.0	1	SNP	p	S88P	0	.	.	262	264	TCC	546	548	TCC	148;147;148	T;C;C	143;143;144	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3330	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2632	124.8	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1239	1241	TGC	157;155;157	T;G;C	146;146;148	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3330	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2632	124.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1449	1451	GGC	138;136;134	G;G;C,A	135;133;130,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1177	1179	GCA	179;183;185	G;C;A	167;168;174	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1180	1182	ATC	186;185;183	A;T;C	176;173;170	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1192	1194	GTG	168;169;171	G,A;T;G	161,1;159;162	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1192	1194	GTG	168;169;171	G,A;T;G	161,1;159;162	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1696	1698	ACC	139;140;139	A;C;C	132;135;133	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1750	1752	GCG	136;137;137	G;C,G;G	130;119,1;130	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1750	1752	GCG	136;137;137	G;C,G;G	130;119,1;130	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1873	1875	GGC	126;122;123	G;G;C,T	119;114;115,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1882	1884	GGC	123;122;120	G;G;C	115;114;113	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3210	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2195	143.9	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1900	1902	TCG	115;114;114	T,G;C,G;G	74,17;98,1;97	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4688	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3160	146.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1659	1661	CCG	139;139;136	C;C;G	131;135;129	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1904	porA	1146	1146	99.56	porA.l15.c17.ctg.1	1733	108.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	141	C	135	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	354	356	GAA	185;184;183	G;A;A	180;177;178	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	642	644	GAT	218;220;219	G;A;T	207;208;208	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	765	767	TCA	199;200;199	T;C;A	193;195;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	A218T	NONSYN	652	654	GCC	894	896	ACC	171;170;172	A,G;C;C	158,1;165;170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	906	908	TCT	185;182;184	T;C;T,A	177;177;178,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1224	1226	GCA	194;194;196	G;C;A	184;184;187	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	1	SNP	p	G120K	1	.	.	358	360	AAG	600	602	AAG	198;201;204	A;A;G	191;193;196	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	1	SNP	p	A121D	1	.	.	361	363	GAC	603	605	GAC	204;203;205	G;A;C	197;193;196	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2430	porB1b	1047	1047	99.24	porB1b.l15.c30.ctg.1	1434	166.7	1	SNP	p	D121N	0	.	.	361	363	GAC	603	605	GAC	204;203;205	G;A;C	197;193;196	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8180	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4840	167.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1988	1990	AAT	166;165;166	A;A;T	162;160;160	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1074	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1037	101.7	1	SNP	p	V57M	1	.	.	169	171	ATG	480	482	ATG	202;206;205	A;T;G,T	194;201;197,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
